🇺🇸 FDA
Patent

US 8574853

Monoclonal antibodies that neutralize anthrax toxins

granted A61KA61K2039/505A61K51/1009

Quick answer

US patent 8574853 (Monoclonal antibodies that neutralize anthrax toxins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K51/1009, A61P, A61P31/04